ribociclib and Colonic-Neoplasms

ribociclib has been researched along with Colonic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for ribociclib and Colonic-Neoplasms

Article	Year
Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer. Oncology (Williston Park, N.Y.), 2018, Oct-15, Volume: 32, Issue:10 Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Carcinoma, Lobular; Colonic Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Humans; Letrozole; Middle Aged; Neoplasm Metastasis; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone	2018

Article

Year

Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer.

Oncology (Williston Park, N.Y.), 2018, Oct-15, Volume: 32, Issue:10

Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Carcinoma, Lobular; Colonic Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Humans; Letrozole; Middle Aged; Neoplasm Metastasis; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone

2018